Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$61.03 - $69.57 $1,342 - $1,530
22 Added 3.01%
753 $51,000
Q4 2023

Jan 30, 2024

SELL
$61.89 - $69.28 $141,604 - $158,512
-2,288 Reduced 75.79%
731 $49,000
Q3 2023

Oct 30, 2023

SELL
$64.85 - $71.7 $73,410 - $81,164
-1,132 Reduced 27.27%
3,019 $204,000
Q2 2023

Jul 17, 2023

BUY
$69.91 - $75.81 $290,196 - $314,687
4,151 New
4,151 $294,000
Q3 2022

Oct 31, 2022

BUY
$53.02 - $135.75 $6,415 - $16,425
121 Added 13.67%
1,006 $55,000
Q2 2022

Jul 19, 2022

BUY
$59.26 - $71.14 $52,445 - $62,958
885 New
885 $58,000
Q1 2022

May 03, 2022

SELL
$55.72 - $67.12 $3,231 - $3,892
-58 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$54.02 - $63.83 $3,133 - $3,702
58 New
58 $3,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.